Form 4: Celanese Corp: SVP Acetyls, Mark Christopher Murray, Reports Stock Option Grant

Mark Christopher Murray, SVP Acetyls at Celanese Corp, reports the acquisition of 8,804 nonqualified stock options on February 28, 2024.

Summary

• On February 28, 2024, Mark Christopher Murray, SVP Acetyls at Celanese Corp, acquired 8,804 nonqualified stock options.
• The options were granted under the company's Amended and Restated 2018 Global Incentive Plan.
• The exercise price of the options is $149.09.
• The options vest in three annual installments beginning February 15, 2025, subject to continued employment.
• The expiration date for the options is February 27, 2034.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard executive compensation disclosure. The grant itself is neither particularly positive nor negative.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule incentivizes continued employment with Celanese Corp.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the chemical industry, similar to companies like Dow Chemical and BASF.
• The vesting schedule of three years is also typical for these types of grants.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the executive's performance leads to an increase in the company's stock price.
• The grant incentivizes the executive to remain with the company, providing stability.

Key Dates